Prostate Cancer

Prostate cancer is the most common non-skin cancer in the United States and the third most common cancer worldwide. More than 1 million men in the United States have prostate cancer and it is the second leading cause of cancer death amongst men after lung cancer. In 2009, an estimated 192,280 new cases are expected to be diagnosed and approximately 27,360 men are expected to die from the disease. Castration-resistant prostate cancer (CRPC) is defined as prostate cancer that continues to grow despite all standard-of-care hormonal (anti-androgen) therapies. Patients with castration-resistant (also known as hormone-refractory) prostate cancer have few treatment options and a poor prognosis.
Prostate Cancer

Prostate cancer is one of the most common cancers in men, with more than 40,000 new cases diagnosed every year in the UK. This is usually a slow growing cancer and most men do not notice the symptoms until the cancer has become large enough to press against the urethra and interfere with urination.

Read More

Overview

Feature Articles

Latest Prostate Cancer News and Research

PET/MRI reduces radiation exposure, improves lesion detectability in select cancers

PET/MRI reduces radiation exposure, improves lesion detectability in select cancers

UTHSC professor receives $455,000 grant to study cause of aggressive prostate cancer

UTHSC professor receives $455,000 grant to study cause of aggressive prostate cancer

New nanomedicine is efficient and less aggressive than conventional prostate cancer therapy

New nanomedicine is efficient and less aggressive than conventional prostate cancer therapy

Researchers receive $2.5 million grant to develop and analyze breast tumor organoids

Researchers receive $2.5 million grant to develop and analyze breast tumor organoids

High-intensity focused ultrasound technology shows promising outcomes for prostate cancer

High-intensity focused ultrasound technology shows promising outcomes for prostate cancer

Six genomics research projects receive grants to address the role of ethnicity in major cancers

Six genomics research projects receive grants to address the role of ethnicity in major cancers

Focal high-intensity focused ultrasound ablation is an effective treatment for prostate cancer

Focal high-intensity focused ultrasound ablation is an effective treatment for prostate cancer

Understanding mechanisms in prostate cancer metastases can provide treatment opportunities

Understanding mechanisms in prostate cancer metastases can provide treatment opportunities

Dartmouth receives $2.5 million to develop device for detecting tumor left behind during surgery

Dartmouth receives $2.5 million to develop device for detecting tumor left behind during surgery

Enzalutamide has added benefit for men with castration-resistant prostate cancer at high risk of metastasis

Enzalutamide has added benefit for men with castration-resistant prostate cancer at high risk of metastasis

Study shows how PIM kinases enhance cancer cell motility

Study shows how PIM kinases enhance cancer cell motility

PARP inhibitor can successfully treat a subset of advanced prostate cancer patients

PARP inhibitor can successfully treat a subset of advanced prostate cancer patients

Radiation therapy delay for prostate cancer patients offers room for flexibility during the pandemic

Radiation therapy delay for prostate cancer patients offers room for flexibility during the pandemic

Study uses a statistical approach to reveal patterns of cancer incidence

Study uses a statistical approach to reveal patterns of cancer incidence

Developing a blood test for prostate cancer

Developing a blood test for prostate cancer

Simple process could enhance personalization of cancer therapy

Simple process could enhance personalization of cancer therapy

Darolutamide shows indication of considerable added benefit in prostate cancer

Darolutamide shows indication of considerable added benefit in prostate cancer

New method to detect rare circulating tumor cells in blood samples

New method to detect rare circulating tumor cells in blood samples

New blood test can detect prostate cancer and confirm the stage of the disease

New blood test can detect prostate cancer and confirm the stage of the disease

Combination of certain drugs can do more harm than good, shows study

Combination of certain drugs can do more harm than good, shows study